DK3231803T3 - Dihydroindolizinonderivat - Google Patents

Dihydroindolizinonderivat Download PDF

Info

Publication number
DK3231803T3
DK3231803T3 DK15867764.1T DK15867764T DK3231803T3 DK 3231803 T3 DK3231803 T3 DK 3231803T3 DK 15867764 T DK15867764 T DK 15867764T DK 3231803 T3 DK3231803 T3 DK 3231803T3
Authority
DK
Denmark
Prior art keywords
dihydroindolizinon
derivatives
dihydroindolizinon derivatives
Prior art date
Application number
DK15867764.1T
Other languages
English (en)
Inventor
Motoyuki Tanaka
Takashi Kondo
Yasuo Hirooka
Taihei Nishiyama
Atsushi Hiramatsu
Tomoyuki Koda
Sho Kouyama
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Application granted granted Critical
Publication of DK3231803T3 publication Critical patent/DK3231803T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK15867764.1T 2014-12-10 2015-12-09 Dihydroindolizinonderivat DK3231803T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2014249822 2014-12-10
JP2014263251 2014-12-25
JP2015046150 2015-03-09
JP2015160632 2015-08-17
PCT/JP2015/084573 WO2016093285A1 (ja) 2014-12-10 2015-12-09 ジヒドロインドリジノン誘導体

Publications (1)

Publication Number Publication Date
DK3231803T3 true DK3231803T3 (da) 2020-08-24

Family

ID=56107463

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15867764.1T DK3231803T3 (da) 2014-12-10 2015-12-09 Dihydroindolizinonderivat

Country Status (22)

Country Link
US (6) US10065955B2 (da)
EP (2) EP3702357B1 (da)
JP (3) JP6610562B2 (da)
KR (1) KR102525392B1 (da)
CN (1) CN107001363B (da)
AU (1) AU2015362422B2 (da)
BR (1) BR112017012146B1 (da)
CA (1) CA2970233C (da)
DK (1) DK3231803T3 (da)
ES (2) ES2927307T3 (da)
HU (1) HUE051080T2 (da)
IL (1) IL252777B (da)
MX (2) MX385021B (da)
MY (1) MY194106A (da)
PH (1) PH12017501067B1 (da)
PL (1) PL3231803T3 (da)
PT (1) PT3231803T (da)
RU (1) RU2707887C2 (da)
SG (1) SG11201704708QA (da)
TW (1) TWI696620B (da)
WO (1) WO2016093285A1 (da)
ZA (1) ZA201704602B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2760821T3 (da) 2014-01-31 2018-03-10
JP6505727B2 (ja) 2014-01-31 2019-04-24 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company ヘテロ環式p2’基を有する第xia因子阻害剤としてのマクロ環
JP6526796B2 (ja) 2014-09-04 2019-06-05 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Fxia阻害剤であるジアミドマクロ環
US9453018B2 (en) 2014-10-01 2016-09-27 Bristol-Myers Squibb Company Pyrimidinones as factor XIa inhibitors
JP6992284B2 (ja) * 2016-06-06 2022-01-13 小野薬品工業株式会社 ジヒドロインドリジノン誘導体を含有する医薬組成物
AU2019390094A1 (en) * 2018-11-30 2021-06-17 Ono Pharmaceutical Co., Ltd. Novel crystal of (3S)-3-[2-(6-amino-2-fluoropyridine-3-yl)-4-fluoro-1h-imidazole-5-yl]-7-[5-chloro-2-(1h-tetrazole-1-yl)phenyl]-2,3-dihydroindolizine-5(1h)-one
KR102242187B1 (ko) * 2019-06-04 2021-04-20 주식회사 우정바이오 실내 표면 및 공기 살균 정화 장치
US11518766B2 (en) 2019-06-28 2022-12-06 Shanghai Jemincare Pharmaceuticals Co., Ltd. Tricyclic compound, preparation method therefor and use thereof
CA3189771A1 (en) 2020-07-22 2022-01-27 Janssen Pharmaceutica Nv Compounds useful as factor xia inhibitors
JP2024125436A (ja) * 2021-07-20 2024-09-19 小野薬品工業株式会社 イミダゾール化合物の製造方法
CN118974045A (zh) * 2022-03-21 2024-11-15 上海济煜医药科技有限公司 三并环类化合物制备方法及其中间体
JP2025513455A (ja) 2022-04-22 2025-04-24 バーテックス ファーマシューティカルズ インコーポレイテッド 疼痛の治療のためのヘテロアリール化合物
CN117800970B (zh) * 2022-05-16 2026-08-11 上海美悦生物科技发展有限公司 螺环类衍生物及其药物组合物、制备方法和用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61385A (en) * 1979-12-06 1984-11-30 Labaz Sanofi Nv 3-(4-(dialkylaminoalkyl)-oxy-benzoyl)-indolizine derivatives,their preparation and pharmaceutical compositions containing them
EP0407342A3 (en) 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
DE4221583A1 (de) 1991-11-12 1993-05-13 Bayer Ag Substituierte biphenylpyridone
DE4407488A1 (de) 1994-03-07 1995-09-14 Bayer Ag Verwendung von Biphenyl- und Pyridylmethylpyridonen
IT1277405B1 (it) * 1995-08-01 1997-11-10 Menarini Farma Ind Derivati di lattami biciclici come inibitori della trombina
AP1822A (en) 2002-02-14 2008-01-30 Pharmacia Corp Substituted pyridinones as modulators of P38 MAP kinase.
FR2838123B1 (fr) * 2002-04-04 2005-06-10 Sanofi Synthelabo Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
MXPA06001601A (es) 2003-08-13 2006-08-25 Takeda Pharmaceutical Derivados de 4-pirimidona y su uso como inhibidores de dipeptidilpeptidasa.
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
JP5225098B2 (ja) 2005-12-14 2013-07-03 ブリストル−マイヤーズ スクイブ カンパニー 第XIa因子インヒビターとしてのアリールプロピオンアミド、アリールアクリルアミド、アリールプロピンアミド、またはアリールメチルウレアアナログ
US7803940B2 (en) 2006-11-24 2010-09-28 Takeda Pharmaceutical Company Limited Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases
EA200970510A1 (ru) 2006-11-24 2009-12-30 Такеда Фармасьютикал Компани Лимитед Гетеромоноциклическое соединение и его применение
ES2546815T3 (es) 2006-12-15 2015-09-28 Bristol-Myers Squibb Company Análogos de arilpropilamida, arilacrilamida, arilpropinamida o arilmetilurea como inhibidores del factor XIa
EP2268636A1 (en) 2007-12-11 2011-01-05 Schering Corporation Gamma secretase modulators
EP2625170A1 (en) 2010-10-07 2013-08-14 Takeda Pharmaceutical Company Limited 1,4-oxazepane derivatives
TW201319068A (zh) * 2011-08-05 2013-05-16 必治妥美雅史谷比公司 作為xia因子抑制劑之環狀p1接合劑
WO2013093484A1 (en) * 2011-12-21 2013-06-27 Ono Pharmaceutical Co., Ltd. Pyridinone and pyrimidinone derivatives as factor xia inhibitors
GB2497806A (en) * 2011-12-21 2013-06-26 Ono Pharmaceutical Co Pyridinone and pyrimidinone derivatives as factor XIa inhibitors
WO2015120777A1 (zh) 2014-02-14 2015-08-20 四川海思科制药有限公司 一种吡啶酮或嘧啶酮衍生物、及其制备方法和应用
CN105658641B (zh) * 2014-07-25 2018-04-17 江苏恒瑞医药股份有限公司 氮茚‑酰胺类衍生物、其制备方法及其在医药上的应用

Also Published As

Publication number Publication date
US20230138003A1 (en) 2023-05-04
AU2015362422A1 (en) 2017-07-27
TWI696620B (zh) 2020-06-21
MX2017007551A (es) 2017-10-31
BR112017012146B1 (pt) 2023-11-21
EP3231803B1 (en) 2020-07-01
PH12017501067B1 (en) 2020-11-27
PH12017501067A1 (en) 2017-12-04
JP2021011506A (ja) 2021-02-04
WO2016093285A1 (ja) 2016-06-16
JPWO2016093285A1 (ja) 2017-09-21
JP2020012004A (ja) 2020-01-23
CN107001363A (zh) 2017-08-01
HUE051080T2 (hu) 2021-03-01
BR112017012146A2 (pt) 2018-01-02
CA2970233A1 (en) 2016-06-16
RU2707887C2 (ru) 2019-12-02
MX2021005869A (es) 2021-07-16
PT3231803T (pt) 2020-09-03
US10407426B2 (en) 2019-09-10
US20190352304A1 (en) 2019-11-21
PL3231803T3 (pl) 2020-11-02
ES2814098T3 (es) 2021-03-26
KR20170095845A (ko) 2017-08-23
ES2927307T3 (es) 2022-11-04
US20170349580A1 (en) 2017-12-07
US10065955B2 (en) 2018-09-04
IL252777A0 (en) 2017-08-31
KR102525392B1 (ko) 2023-04-24
US11566027B2 (en) 2023-01-31
CN107001363B (zh) 2019-06-21
NZ733574A (en) 2024-03-22
US20180334458A1 (en) 2018-11-22
RU2017124150A (ru) 2019-01-09
MX385021B (es) 2025-03-14
EP3702357B1 (en) 2022-08-24
US20200140435A1 (en) 2020-05-07
US10550119B2 (en) 2020-02-04
JP6791338B2 (ja) 2020-11-25
JP6610562B2 (ja) 2019-11-27
ZA201704602B (en) 2018-08-29
EP3231803A1 (en) 2017-10-18
MY194106A (en) 2022-11-13
US10815233B2 (en) 2020-10-27
AU2015362422B2 (en) 2019-11-14
US20210009586A1 (en) 2021-01-14
CA2970233C (en) 2023-01-03
EP3231803A4 (en) 2018-08-08
SG11201704708QA (en) 2017-07-28
IL252777B (en) 2020-11-30
RU2017124150A3 (da) 2019-07-17
EP3702357A1 (en) 2020-09-02
TW201629059A (zh) 2016-08-16

Similar Documents

Publication Publication Date Title
NL301275I2 (nl) zilucoplan
DK3183051T3 (da) Væske-til-luftmembranenergivekslere
DK3134402T3 (da) 4-amino-imidazoquinolinforbindelser
DK3211743T3 (da) Ø-til-netværk-omskiftningsfremgangsmåde
DK3006072T3 (da) Karadgang
LT3204359T (lt) Tetrahidroizochinolino dariniai
DK3222714T3 (da) Phytasemutanter
DK3119396T3 (da) Muscarinreceptoragonister
NO2024061I1 (no) Fruquintinib
EP3230438C0 (en) N-GLYCOSYLATION
HUE048321T2 (hu) Karabazol származékok
EP4011484C0 (en) CARBONIC ANHYDRASE OF THERMOVIBRIO AMMONIFICANS
DK4242916T3 (da) Forstøver
DK3183340T3 (da) Termolabile exonukleaser
DE112015001664A5 (de) Betätigungsaktuator
LT3371168T (lt) Indolin-2-ono dariniai
DK3154703T3 (da) Fuldkappe-snekkecentrifuge
DK3131898T3 (da) Fluoroalkylfluorenderivativer
DE112015005041A5 (de) Gargerätevorrichtung
DK3110439T3 (da) Pcsk9-vacciner
DE102014000623A8 (de) Halbhohlnietelement
PL3137460T3 (pl) Pochodne diheterocyklu połączonego cykloalkilem
LT3097076T (lt) Nauji cip-eikozanoidų dariniai
DK3009858T3 (da) Skyradar
DE202014005655U8 (de) llluminationsvorrichtung